Courtagen Releases epiSEEK[TM] World's Most Comprehensive, Rapid, Next Generation Clinical Sequencing Test Targeting 327 Genes Associated with Epilepsy Phenotypes

MLA

“Courtagen Releases EpiSEEK[TM] World’s Most Comprehensive, Rapid, Next Generation Clinical Sequencing Test Targeting 327 Genes Associated with Epilepsy Phenotypes.” Business Wire, 31 Oct. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.306903532&authtype=sso&custid=ns315887.

APA

Courtagen Releases epiSEEK[TM] World’s Most Comprehensive, Rapid, Next Generation Clinical Sequencing Test Targeting 327 Genes Associated with Epilepsy Phenotypes. (2012, October 31). Business Wire.

Chicago

Business Wire. 2012. “Courtagen Releases EpiSEEK[TM] World’s Most Comprehensive, Rapid, Next Generation Clinical Sequencing Test Targeting 327 Genes Associated with Epilepsy Phenotypes,” October 31. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.306903532&authtype=sso&custid=ns315887.